Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in […]
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the […]
Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might.
Apogee Therapeutics (NASDAQ:APGE) Reaches New 52-Week High at $33 87 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.